Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/all.14498 http://scihub22266oqcxt.onion/10.1111/all.14498 32658359!7404682!32658359     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Allergy 2021 ; 76 (3): 698-713 Nephropedia Template TP {{tp|p=32658359|t=2021. SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?|pdf=|usr=}}{{32658359}} gab.com Text SARS-CoV-2, COVID-19, skin and immunology - What do we know so far JO: Allergy http://www.kidney.de/pget.php?&tw=1&pmid=32658359 #FOAvip The pandemic condition coronavirus disease (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can take asymptomatic, mild, moderate, and severe courses. COVID-19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatigue, and diarrhea and can end up in interstitial pneumonia and severe respiratory failure. Reports about the manifestation of various skin lesions and lesions of the vascular system in some subgroups of SARS-CoV-2-positive patients as such features outside the respiratory sphere, are rapidly emerging. Vesicular, urticarial, and maculopapular eruptions and livedo, necrosis, and other vasculitis forms have been reported most frequently in association with SARS-CoV-2 infection. In order to update information gained, we provide a systematic overview of the skin lesions described in COVID-19 patients, discuss potential causative factors, and describe differential diagnostic evaluations. Moreover, we summarize current knowledge about immunologic, clinical, and histologic features of virus- and drug-induced lesions of the skin and changes to the vascular system in order to transfer this knowledge to potential mechanisms induced by SARS-CoV-2. Twit Text FOAVip SARS-CoV-2, COVID-19, skin and immunology - What do we know so far ????Allergy http://www.kidney.de/pget.php?&tw=1&pmid=32658359 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32658359 #FOAvip English Wikipedia <ref>{{Cite pmid|32658359}}</ref> SARS-CoV-2, COVID-19, skin and immunology - What do we know so far? #MMPMID32658359 Novak N; Peng W; Naegeli MC; Galvan C; Kolm-Djamei I; Bruggen C; Cabanillas B; Schmid-Grendelmeier P; Catala A Allergy 2021[Mar]; 76 (3): 698-713 PMID32658359show ga The pandemic condition coronavirus disease (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can take asymptomatic, mild, moderate, and severe courses. COVID-19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatigue, and diarrhea and can end up in interstitial pneumonia and severe respiratory failure. Reports about the manifestation of various skin lesions and lesions of the vascular system in some subgroups of SARS-CoV-2-positive patients as such features outside the respiratory sphere, are rapidly emerging. Vesicular, urticarial, and maculopapular eruptions and livedo, necrosis, and other vasculitis forms have been reported most frequently in association with SARS-CoV-2 infection. In order to update information gained, we provide a systematic overview of the skin lesions described in COVID-19 patients, discuss potential causative factors, and describe differential diagnostic evaluations. Moreover, we summarize current knowledge about immunologic, clinical, and histologic features of virus- and drug-induced lesions of the skin and changes to the vascular system in order to transfer this knowledge to potential mechanisms induced by SARS-CoV-2. |*SARS-CoV-2[MESH] |Angiotensin-Converting Enzyme 2/analysis[MESH] |COVID-19/*complications/immunology/pathology/transmission[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Skin Diseases/*etiology/pathology[MESH]SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?(epmc).pdf DeepDyve Pubget Overpricing